Filing Details

Accession Number:
0001181431-12-035554
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-06-08 16:05:43
Reporting Period:
2012-06-06
Filing Date:
2012-06-08
Accepted Time:
2012-06-08 16:05:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1325879 Aveo Pharmaceuticals Inc AVEO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1486519 Brannon David Johnston C/O Aveo Pharmaceuticals, Inc.
75 Sidney Street
Cambridge MA 02139
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-06-06 15,000 $5.60 40,154 No 4 M Direct
Common Stock Disposition 2012-06-06 15,000 $12.21 25,154 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right-to-buy) Disposition 2012-06-06 15,000 $0.00 15,000 $5.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
150,000 2017-10-31 No 4 M Direct
Footnotes
  1. The option vested as to 25% of the shares on October 31, 2008 and as to an additional 1/48 of the shares per month thereafter.